Geusens, P.
van den Bergh, J.
Roux, C.
Chapurlat, R.
Center, J.
Bliuc, D.
Wyers, C.
Javaid, M. K.
Li, N.
Whittier, D.
Lems, W. F.
Article History
Accepted: 28 August 2024
First Online: 10 September 2024
Declarations
:
: P.G. Grants from Sandoz, Celltrion, Fresenius, MSD, Amgen, Galapagos, Viatrix, Biocon. None in the context of this paperJ.V. Grants from UCB and AmgenC.R. Grants from Alexion. None in the context of this paperR.C. Amgen, UCB, Lilly, BMS, Pfizer, Alfasigma, Galapagos, Amolyt, Alexion, Biocon, Novartis, Fresenius-Kabi, Medac, Nordic, Viatris, AbbvieJ.C. Honoraria and advisory board for Amgen. None related to this paperD.B. noneC.W. noneN.L. noneD.W. noneW.L. speakers fee/advisory boards Amgen, UCB, Pfizer, Galapagos.